Wednesday, May 06, 2015 3:31:02 AM
* Completed final pre-clinical studies required by the FDA
* Signed LOI with MD Anderson for Phase 1 clinical development
* Filing IND and initiating Phase 1:
- Investigational New Drug Application filed with the FDA in April 2015
- Begin Phase 1 -> third quarter calendar 2015
- Completed -> end of 2016
http://www.slideshare.net/CriticalOutcome/more-than-just-a-potential-breakthrough-treatment-for-many-cancers
https://twitter.com/CriticalOutcome/with_replies
$COTQF ~ $COT.V
YOU SHOULD NOT MAKE ANY DECISION, FINANCIAL, INVESTMENTS, TRADING OR OTHERWISE, BASED ON ANY OF THE INFORMATION PRESENTED IN THIS MESSAGE WITHOUT UNDERTAKING INDEPENDENT DUE DILIGENCE AND CONSULTATION WITH A PROFESSIONAL BROKER OR FINANCIAL ADVISOR.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM